Predictors of cervical tumour size for outpatients with cervical cancer at the University of Gondar referral hospital: a retrospective study design

Table 6 Results of the final LMM for cervical cancer outpatients, UoGRH, 2017–2021

Covariate	Category	Estimate	Std. error	95% CI		p-value
Covariate	Category	Estimate	Std. error	Lower	Upper	p-value
	Intercept	4.56	0.25	4.07	5.05	0.0001
Treatment	(ref = radiotherapy)
	Chemotherapy	0.17	0.08	0.008	0.33	0.0401
	Surgery	0.19	0.09	0.007	0.37	0.0425
Weight		− 0.009	0.004	− 0.02	− 0.0005	0.0396
Histology	(ref = Adenocarcinoma)
Histology	Squamous cell carcinoma	− 0.06	0.11	− 0.27	0.16	0.6104
Stage of cancer	(ref = early)
Stage of cancer	Late	0.22	0.09	0.04	0.40	0.0198
HIV	No
HIV	Yes	0.44	0.12	0.21	0.67	0.0002
Oral contraceptive use	(ref = No)
Oral contraceptive use	Yes	0.29	0.11	0.07	0.51	0.0100
Comorbid disease	(ref = No)
Comorbid disease	Yes	0.09	0.09	− 0.09	0.27	0.3321
History of abortion	(ref = No)
History of abortion	Yes	0.23	0.09	0.05	0.42	0.0128
Smoking status	(ref = No)
Smoking status	Yes	0.23	0.11	0.08	0.52	0.0090
visit time		− 0.009	0.002	− 0.012	− 0.006	0.0001
Random effect	Std.Dev	95%CI
Random effect	Std.Dev	Lower	Upper
Intercept (b_0i)	0.47	0.39	0.56
Visit time (b_1i)	0.01	0.001	0.02
Corr (b_0i, b_1i)	0.58	0.30	0.93
Residual (ε_i	0.33	0.07	0.82

Std.Dev = standard deviation. ref = reference category, bold indicates significance of variable at 5%

ISSN: 2047-783X